Hemodynamic effects by glucagon-like peptide-1 receptor analogues: what should be measured?

Nilsson, Peter M

Hemodynamic effects by glucagon-like peptide-1 receptor analogues: what should be measured? [electronic resource] - Journal of hypertension 05 2017 - 953-954 p. digital

Publication Type: Editorial; Research Support, Non-U.S. Gov't; Comment

1473-5598

10.1097/HJH.0000000000001315 doi


Glucagon-Like Peptide 1
Glucagon-Like Peptide-1 Receptor
Hemodynamics
Humans
Insulin
Peptide Fragments
Peptides